Chapter title |
Synthetic mRNA
|
---|---|
Chapter number | 18 |
Book title |
Synthetic mRNA
|
Published in |
Methods in molecular biology, January 2016
|
DOI | 10.1007/978-1-4939-3625-0_18 |
Pubmed ID | |
Book ISBNs |
978-1-4939-3623-6, 978-1-4939-3625-0
|
Authors |
Coosemans, An, Tuyaerts, Sandra, Morias, Kim, Corthals, Jurgen, Heirman, Carlo, Thielemans, Kris, Van Gool, Stefaan W, Vergote, Ignace, Amant, Frédéric, An Coosemans, Sandra Tuyaerts, Kim Morias, Jurgen Corthals, Carlo Heirman, Kris Thielemans, Stefaan W. Van Gool, Ignace Vergote, Frédéric Amant, Gool, Stefaan W. Van |
Abstract |
The immune system is a crucial player in the development of cancer. Once it is in imbalance and immunosuppressive mechanisms supporting tumor growth take over control, dendritic cell immunotherapy might offer a solution to restore the balance. There are several methods to manufacture dendritic cells but none of them has yet proven to be superior to others. In this chapter, we discuss the methodology using electroporation of mRNA encoding Wilms' tumor gene 1, survivin, and TriMix (mixture of caTLR4, CD40L, and CD70) to simultaneously load and mature dendritic cells. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Science communicators (journalists, bloggers, editors) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 9 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 2 | 22% |
Other | 1 | 11% |
Student > Doctoral Student | 1 | 11% |
Student > Master | 1 | 11% |
Researcher | 1 | 11% |
Other | 1 | 11% |
Unknown | 2 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Immunology and Microbiology | 3 | 33% |
Agricultural and Biological Sciences | 2 | 22% |
Medicine and Dentistry | 2 | 22% |
Unknown | 2 | 22% |